SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

GenMark Diagnostics Reaffirms FY2019 Sales Guidance of $85M-90M vs $87.86M

GenMark Diagnostics (NASDAQ:GNMK) . raises FY2019 sales outlook from $85 million-90 million to $85 million-90 million.

Benzinga · -

GenMark Diagnostics (NASDAQ:GNMK) . raises FY2019 sales outlook from $85 million-90 million to $85 million-90 million.